Get the Stockscreener App
36.87
7.37%
2.53
After Hours:
37.15
0.28
+0.76%
Twist Bioscience Corp stock is traded at $36.87, with a volume of 2.01M.
It is up +7.37% in the last 24 hours and up +14.15% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$34.34
Open:
$34.57
24h Volume:
2.01M
Relative Volume:
1.26
Market Cap:
$2.25B
Revenue:
$362.27M
Net Income/Loss:
$-85.19M
P/E Ratio:
-25.43
EPS:
-1.45
Net Cash Flow:
$-68.71M
1W Performance:
+14.68%
1M Performance:
+14.15%
6M Performance:
-3.41%
1Y Performance:
-24.00%
1-Day Range:
$34.50
$37.47
1-Week Range:
$31.00
$37.47
52-Week Range:
$23.30
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
36.87 | 2.10B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience (NASDAQ:TWST) Trading 7.4% HigherShould You Buy? - MarketBeat
Cathie Wood’s ARK buys Beam and Twist Bioscience stocks, sells Roku - Investing.com India
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) - Insider Monkey
Cathie Wood’s ARK makes strategic stock moves, buys Intellia and sells Roku - Investing.com
Twist Bioscience2025 Funding Rounds & List of Investors - Tracxn
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 1,605 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Stock Price Down 4.1%Time to Sell? - MarketBeat
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Finviz
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025) - ts2.tech
What valuation multiples suggest for Twist Bioscience Corporation stock2025 Price Targets & Low Risk High Reward Trade Ideas - Улправда
Will Twist Bioscience Corporation (0ME) stock remain on Wall Street radarTrade Ideas & Verified Swing Trading Watchlist - Улправда
Is Twist Bioscience Corporation (0ME) stock a contrarian opportunityPortfolio Growth Summary & Weekly Chart Analysis and Guides - DonanımHaber
Published on: 2025-12-18 20:43:14 - Улправда
Twist Bioscience (TWST): Evaluating Valuation After New Research‑Grade Plasmid DNA Preps Launch - simplywall.st
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference - Business Wire
Squarepoint Ops LLC Raises Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Up 6.4%Should You Buy? - MarketBeat
Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - ts2.tech
Aptamer Group Signs First Licensing Deal With Twist Bioscience - DirectorsTalk Interviews
Aptamer Group PLCLicensing agreement with Twist Bioscience - Research Tree
Aptamer Group signs licensing deal with Twist Bioscience for NGS market - Investing.com Canada
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 - GuruFocus
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 | TWST Stock News - GuruFocus
Is Twist’s New High‑Quality Plasmid DNA Preps Business Altering The Investment Case For Twist Bioscience (TWST)? - simplywall.st
Nikko Asset Management Americas Inc. Sells 116,361 Shares of Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corporation $TWST Stock Holdings Lifted by EdgePoint Investment Group Inc. - MarketBeat
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
DNA Computing Market - GlobeNewswire Inc.
Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 - MSN
VP Green Surrenders 877 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
VP Green Files To Sell 877 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
VP Cho Files To Sell 398 Of Twist Bioscience Corp [TWST] - TradingView — Track All Markets
Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest - Yahoo Finance
How Twist’s New Preclinical-Grade Plasmid DNA Preps Could Reshape the TWST Nucleic Acid Therapeutics Story - Yahoo Finance
Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST? - simplywall.st
Twist Bioscience Corp. Hits New 52-Week Low at $23.50 - Markets Mojo
Twist Bioscience Introduces New Plasmid DNA Preparation Products - marketscreener.com
Can Twist Bioscience Corporation (0ME) stock survive global slowdown2025 Risk Factors & Free Safe Entry Trade Signal Reports - Newser
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Business Wire
How analysts revise price targets for Twist Bioscience Corporation (0ME) stockStock Surge & Safe Swing Trade Setups - Newser
Virtus Advisers LLC Cuts Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare - GlobeNewswire Inc.
A 'renter’s market' allowed this CEO to bring everyone together for lessSan Francisco Business Times - The Business Journals
Franklin Resources Inc. Decreases Stock Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corporation $TWST Stake Raised by XTX Topco Ltd - MarketBeat
Published on: 2025-11-28 09:12:39 - moha.gov.vn
Twist Bioscience Corp. Hits Day High with 9.55% Surge in Stock Price - Markets Mojo
Twist Bioscience Stock Hits Day Low of $25.51 Amid Price Pressure - Markets Mojo
Twist Bioscience Stock Hits Day Low of $23.50 Amid Price Pressure - Markets Mojo
Twist Bioscience Opens Weak with 10.57% Gap Down Amid Market Concerns - Markets Mojo
Ensign Peak Advisors Inc Has $6.08 Million Stock Holdings in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cho Dennis | See Remarks |
Dec 22 '25 |
Sale |
34.56 |
324 |
11,196 |
144,680 |
| Leproust Emily M. | Chief Executive Officer |
Dec 22 '25 |
Sale |
34.56 |
1,605 |
55,462 |
874,313 |
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):